15
Jun
2026
15
Jun
2026
Lynton has announced the launch of DEKA Exosomes, a regenerative skincare solution designed to support the skin’s natural repair processes and be used alongside a range of aesthetic treatments.
Built on established scientific principles, DEKA Exosomes are intended to complement existing clinic treatments by supporting skin recovery and helping to improve overall skin quality.
They can be used as a standalone treatment or in combination with procedures such as laser treatments and microneedling, where they are designed to support the skin’s natural recovery process.
Exosomes are naturally occurring extracellular vesicles involved in cell-to-cell communication. They are released by cells in the body and carry biological signals that help coordinate repair and regeneration processes.
DEKA Exosomes are designed to work within this natural communication system to support skin renewal and recovery at a cellular level.
DEKA Exosomes can be incorporated into treatment protocols in a number of ways, including after energy-based or skin-rejuvenation procedures.
They are intended to support:
By working alongside existing procedures, they offer clinics an additional option to support patients during the post-treatment recovery phase.
Interest in regenerative approaches to skin health continues to increase, with more clinics exploring treatments that align with the body’s natural biological processes.
DEKA Exosomes are positioned as an additional option for clinics looking to expand their regenerative skincare offering while continuing to work within established treatment pathways.
"At Lynton, we're always looking for ways to help our customers stay at the forefront of aesthetics," says Hayley Jones, Commercial Director at Lynton.
"Regenerative skincare is one of the most exciting areas of growth within our industry, and DEKA Exosomes give practitioners access to a science-led solution that works alongside the body’s natural repair processes. We’re excited to bring this innovation to the UK market and support clinics in delivering excellent patient outcomes with confidence."
The launch of DEKA Exosomes forms part of Lynton’s ongoing focus on providing technology and solutions for the aesthetics sector.
For more than 30 years, the company has supplied aesthetic systems alongside training, clinical education, and customer support for clinics across the UK.
Clinics adopting DEKA Exosomes will also have access to training, marketing materials, and ongoing guidance to support safe and effective integration into practice.
For further information or to arrange a demonstration:
Read it? Loved it? Want to share it?
